fbpx

MS heat sensitivity – how to keep cool

How to keep cool when you have MS Published: 10 August 2022 Feeling hot? Our Helpline Officer Shaun has six quick and easy tips to keep cool this summer when you have MS heat sensitivity For some people affected by multiple sclerosis (MS), summer can be a time of concern
Read More

Zeposia helps cognitive function

Zeposia helps cognitive functionPublished 09 August Zeposia (ozanimod) can help to stabilise or even improve cognition in people with multiple sclerosis (MS) according to a phase 3 clinical trial. Zeposia is taken orally and works by keeping immune cells within the lymph nodes, preventing them crossing into the brain and
Read More

Intermittent fasting may benefit MS

Intermittent fasting may benefit MS Published 04 August People with multiple sclerosis (MS) who undertook an eight-week intermittent fasting plan had immune and metabolic changes according to a new small study. Researchers enrolled 36 patients and split them into three groups. In the control diet, patients received 100 per cent
Read More

12 of the best mental health apps

Mental health apps Mobile phone or tablet apps can be really useful for supporting your mental wellbeing, so here we take a look at what is available in the app store at the moment. At MS-UK, we believe in offering people affected by multiple sclerosis (MS) as much information as
Read More

Treatment shows remyelination promise

Treatment shows remyelination promisePublished 08 June 2022 A new experimental treatment has been shown to promote the restoration of the myelin sheath in preclinical models of the disease. ABX-002, which is being developed by Autobahn Therapeutics, is a thyromimetic – a lab-made molecule which is designed to mimic the activity
Read More

Smell test might predict DMT affectiveness

Smell test might help predict DMT effectivenessPublished 04 April 2022 A smell test could be used to tell whether treatments for multiple sclerosis (MS) are working or not, a new study suggests. Researchers in Austria teste whether measuring olfactory threshold (OT) could be a way to detect whether a person
Read More

Stopping this DMT during pregnancy increases relapse-related disability risk

Stopping this DMT during pregnancy increases relapse-related disability risk Published: 08 February 2022 People with multiple sclerosis (MS) who stop taking Tysabri (natalizumab) during pregnancy have a significant risk of relapse-related disability, a new study has found.  Researchers analysed data of 255 pregnant women from the German Multiple Sclerosis and
Read More

Treatment that keeps half of people from relapsing for two years

Treatment that keeps half of people from relapsing for two years Published: 04 February 2022 More than half of people with multiple sclerosis (MS) who are treated with self-injected disease-modifying therapies (DMTs) had no evidence of disease activity after two years, a new study has found.  Turkish researchers wanted to
Read More

MS may raise risk of long Covid

MS may raise risk of long Covid Published: 02 February 2022 A new study has found that almost a third of people with multiple sclerosis (MS) who get Covid-19 have symptoms lasting for at least a month.  Researchers reviewed more than 550 cases of people infected with Covid-19 who have
Read More